Core Insights - Nordic and CLEAR have formed a partnership to enhance healthcare information security and streamline access for patients and providers [1][3] - The collaboration aims to address the challenges healthcare organizations face in modernizing their systems while ensuring security and efficiency [1][3] Company Overview - Nordic is a global health and technology consulting company with over 3,300 professionals, supporting more than 700 healthcare organizations worldwide [4] - CLEAR is a secure identity company that provides a reusable identity platform, CLEAR1, compliant with NIST IAL2/AAL2 standards [2] Partnership Details - The partnership will leverage CLEAR's identity platform to simplify and secure user experiences for both patients and providers [1][2] - The goal is to reduce administrative workloads and cybersecurity risks associated with manual identity verification processes [1][3] Benefits of the Collaboration - Patients will experience streamlined access to health information and services without repeated identity checks [3] - Providers can quickly verify individuals, allowing them to focus on delivering care without administrative delays [3]

Core Insights - Qubitera Holdings is set to launch a quantum-safe Electronic Health Record (EHR) and Electronic Medical Record (EMR) platform globally by mid-2027, utilizing post-quantum cryptography to secure patient data against future quantum computing threats [1][4][5] Technical Roadmap - The deployment will occur in five phases: 1. Research and Planning (Q3 – Q4 2025): Audit existing vulnerabilities, select NIST PQC algorithms, and form partnerships [3] 2. Prototype Development (Q1 – Q2 2026): Build a functional prototype and develop a user-friendly interface [3] 3. Pilot Deployment and Optimization (Q3 – Q4 2026): Launch pilot programs in select hospitals and optimize performance [3] 4. Full Global Deployment (Q1 – Q2 2027): Scale the platform globally with interoperability standards [3] 5. Long-Term Innovation (Q3 2027 Onward): Monitor advancements in quantum computing and adapt algorithms [3] Industry Context - The healthcare technology market is experiencing significant growth, with the global AI in healthcare market projected to reach $187.69 billion by 2030, growing at a CAGR of 38.62% from 2025 to 2030 [6] - The health data interoperability market is expected to reach $352.13 billion by 2032, with a CAGR of 22.65% from 2025 to 2032 [7] - The blockchain in healthcare market is projected to reach $193.43 billion by 2034, with a CAGR of 35.08% from 2025 to 2034 [7] Security Needs - Over 500 million healthcare records have been compromised since 2020, with average incident costs reaching $10.93 million in 2024, highlighting the urgent need for secure data sharing solutions [8] Competitive Positioning - Qubitera Holdings aims to lead the digital transformation in healthcare by integrating AI, blockchain, and interoperability, which is seen as a unique market opportunity to improve medical information flow and patient outcomes [9]

Core Insights - Full Alliance Group's subsidiary, Qubitera Holdings, is launching a post-quantum cryptography-based Electronic Health Record (EHR) and Electronic Medical Record (EMR) system, with a comprehensive five-phase technical roadmap aimed for global deployment by mid-2027 [1][5]. Technical Roadmap - **Research and Planning (Q3 – Q4 2025)**: Establish partnerships with hospitals, PQC vendors, and regulatory bodies to ensure compliance and stakeholder alignment [3]. - **Prototype Development (Q1 – Q2 2026)**: Create a functional prototype using ML-KEM encryption and ML-DSA signatures, implement a permissioned blockchain for metadata storage, and develop a user-friendly interface [3]. - **Pilot Deployment and Optimization (Q3 – Q4 2026)**: Launch pilot programs in select hospital networks, optimize PQC performance, and conduct Quantum Key Distribution (QKD) pilots [3]. - **Full Global Deployment (Q1 – Q2 2027)**: Scale the platform globally with cross-border interoperability and maintain cryptographic agility for future updates [3]. - **Long-Term Innovation (Q3 2027 Onward)**: Expand QKD infrastructure for secure data exchanges between global health networks [3]. Industry Context - The healthcare technology market is experiencing significant growth, with the global AI in healthcare market projected to reach $187.69 billion by 2030, growing at a CAGR of 38.62% from 2025 to 2030 [8]. - The health data interoperability market is expected to reach $352.13 billion by 2032, with a CAGR of 22.65% from 2025 to 2032 [8]. - The blockchain in healthcare market is projected to reach $193.43 billion by 2034, with a CAGR of 35.08% from 2025 to 2034 [9]. Security and Demand - Over 500 million healthcare records have been compromised since 2020, with average incident costs reaching $10.93 million in 2024, highlighting the urgent need for secure data sharing solutions [10]. - Qubitera's platform addresses the impending threat of quantum computing to traditional encryption methods and meets the public demand for patient ownership and transparency of medical records [4][5]. Competitive Positioning - Qubitera Holdings aims to architect the infrastructure for healthcare's digital transformation, leveraging the convergence of AI, blockchain, and interoperability to improve medical information flow and patient outcomes [11].

Core Insights - Amwell granted RSUs covering 76,198 shares of its Class A common stock to two new employees as an inducement for their employment [1][2] - The RSUs will vest 25% on the first anniversary of the grant date, with the remaining 75% vesting in equal increments every three months over three years [1] Company Overview - Amwell provides a comprehensive, technology-enabled care platform for payers and health systems, enhancing patient access to affordable and effective care [3] - The platform supports various clinical programs and offers integrated solutions for millions of patients, demonstrating scalability and dependable outcomes [3] - Amwell has been serving major healthcare organizations in the U.S. and globally for nearly two decades [3]

Financial Performance - Heartflow's shares experienced a significant surge of 66% [1] - The AI software platform focusing on heart disease secured $317 million through its IPO [1] Market Dynamics - Heartflow, an AI software platform specializing in heart disease, went public [1]

Core Insights - Health Catalyst reported revenue of $80.72 million for the quarter ended June 2025, reflecting a 6.4% increase year-over-year, and an EPS of $0.04, down from $0.12 in the same quarter last year [1] - The revenue exceeded the Zacks Consensus Estimate of $80.53 million by 0.24%, while the EPS surpassed the consensus estimate of $0.03 by 33.33% [1] Revenue Breakdown - Professional services revenue was $27.85 million, slightly below the average estimate of $27.86 million, representing a year-over-year decline of 1.5% [4] - Technology revenue reached $52.88 million, exceeding the estimated $52.67 million, and showing an 11% increase compared to the previous year [4] Profitability Metrics - Adjusted Gross Profit for Professional Services was reported at $5.11 million, surpassing the average estimate of $4.09 million [4] - Adjusted Gross Profit for Technology was $34.85 million, slightly below the average estimate of $35.35 million [4] Stock Performance - Over the past month, Health Catalyst shares have returned -5.2%, contrasting with a +1.2% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market [3]

Financial Data and Key Metrics Changes - The company reported Q2 2025 revenue of $80.7 million, representing a 6% year-over-year increase and exceeding guidance [31] - Adjusted EBITDA for Q2 2025 was $9.3 million, the highest in the company's history, and also above guidance [34] - The company revised its full-year 2025 revenue guidance to $310 million due to significant impacts from Medicaid and research funding cuts [6][7] - Adjusted gross margin for Q2 2025 was 50%, a decrease of approximately 30 basis points year-over-year [32] Business Line Data and Key Metrics Changes - Technology segment revenue for Q2 2025 was $52.9 million, reflecting an 11% year-over-year growth driven by recurring revenue from new and acquired clients [32] - Professional services revenue for Q2 2025 was $27.8 million, a 1% decline compared to Q2 2024 [32] - Adjusted technology gross margin was 66%, down approximately 140 basis points year-over-year, while adjusted professional services gross margin was 18%, down approximately 190 basis points year-over-year [32][34] Market Data and Key Metrics Changes - The company anticipates that the impacts of Medicaid and research funding cuts will be a headwind not only in 2025 but likely over the next few years [13] - The company has seen delays in signing new platform client contracts due to macroeconomic uncertainty and funding cuts [9][12] Company Strategy and Development Direction - The company is focused on improving profitability and has removed its previously shared 2028 revenue target of $500 million, emphasizing near-term profitability improvements [14] - The strategic focus is on expanding applications revenue, which has been growing at over 20% year-over-year, and leveraging the Ignite platform for cross-selling opportunities [16][17] - The company plans to complete the migration of platform clients to Ignite by mid-2026, which is expected to alleviate some revenue headwinds [27] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the long-term strategy despite current macroeconomic challenges, including inflation and funding cuts [6][14] - The company expects to maintain adjusted EBITDA guidance of $41 million for 2025, despite the revenue reduction [21] - Management acknowledged the need for clients to adjust to new funding realities, which may take time [52] Other Important Information - The company announced a restructuring plan that will impact approximately 9% of its workforce, aimed at improving profitability by over $40 million annually [20] - A new director, Justin Spencer, will join the board effective September 1, bringing relevant experience from the healthcare technology sector [29] - The CEO announced plans to retire effective June 30, 2026, after 15 years in the role [30] Q&A Session Summary Question: How is the Life Science business performing and what level of investment is needed for growth? - Management noted delays in late-stage opportunities in the CareVive business due to research funding cuts but remains confident in the differentiated offering [41][42] Question: Can you explain the market reaction to the recent Medicaid cuts? - Management highlighted a conservative approach among not-for-profit clients, which has led to delays in project initiation as they adjust to funding cuts [50][51] Question: What is the expected EBITDA for 2026? - Management indicated a run rate of approximately $60 million of adjusted EBITDA going into 2026, with potential for additional operating leverage [52][54] Question: What is the contribution of app layer client wins versus external client wins for new platform clients? - Approximately two-thirds of new platform clients have come from existing clients, reflecting strong cross-sell momentum [58][59] Question: How should investors think about growth rates for 2026 and beyond? - Management suggested that growth may be in the low single digits for 2026 due to ongoing macro headwinds, but expects a return to growth as the Ignite migration is completed [66][71]

Core Insights - Doximity is enhancing its capabilities in artificial intelligence by acquiring Pathway Medical for $63 million, aiming to improve its platform for healthcare professionals [1][4] - Pathway Medical has developed an AI-powered clinical reference tool that provides answers to medical questions based on a large structured dataset, which Doximity intends to integrate into its services [2][3] - The acquisition is expected to allow Doximity's platform to serve as a resource for doctors seeking clinical answers, expanding its functionality beyond networking and administrative tasks [3][4] Financial Details - The acquisition deal closed in late July, involving a cash payment of $26 million and potential additional equity grants of up to $37 million [4] Integration and Development - Doximity is actively integrating Pathway's technology, with testing of a combined product already underway involving thousands of doctors [4]

Hackers have stolen login credentials from thousands of people working with the UK’s National Health Service, putting the organization at risk of further cyberattacks, researchers say https://t.co/KmriZpmEfV ...

Core Insights - The U.S. market experienced a slight decline as investors reacted to new earnings reports, economic data, and tariff announcements, particularly regarding semiconductor and pharmaceutical imports [1] - In the current environment characterized by geopolitical risks and policy changes, value investing is highlighted as a favorable strategy, focusing on purchasing undervalued stocks [1] Investment Strategy - Value investing involves buying stocks priced below their intrinsic value, capitalizing on market mispricing to achieve future profits [1] - Earnings yield is a key metric for value investors, calculated as (Annual Earnings per Share/Market Price) x 100, serving as a reverse indicator of the price-to-earnings (P/E) ratio [3] - A high earnings yield suggests a stock may be undervalued, while a low yield indicates potential overvaluation [3] Stock Selection Criteria - An earnings yield greater than 10% is set as a primary screening criterion, supplemented by additional parameters [5] - Estimated EPS growth for the next 12 months must be greater than or equal to the S&P 500, comparing forward EPS estimates with actual EPS [5] - Average daily trading volume over the past 20 days should be at least 100,000, indicating sufficient liquidity [6] - Current stock price must be $5 or higher, and stocks with a Zacks Rank of 1 (Strong Buy) or 2 (Buy) are expected to outperform peers [7] Highlighted Stocks - Barrick Mining Corporation is a leading gold mining company with projected earnings growth of 56% and 24% for 2025 and 2026, respectively, and a Zacks Rank of 1 [8] - Astrana Health, a tech-enabled healthcare provider, anticipates earnings growth of 77% and 49% for 2025 and 2026, respectively, also holding a Zacks Rank of 1 [9][10] - StoneCo Ltd., a fintech company, expects earnings growth of 10.4% and 16% for 2025 and 2026, with a Zacks Rank of 1 [11] - Plains GP Holdings, involved in crude oil transportation and marketing, projects earnings growth of 206% and 24% for 2025 and 2026, respectively, and has a Zacks Rank of 1 [12] - PHINIA Inc., a supplier for the mobility industry, forecasts earnings growth of 14% and 19.5% for 2025 and 2026, respectively, and holds a Zacks Rank of 1 [13]